ArticleJournal of Korean medical science2020
Information and Misinformation on COVID-19: a Cross-Sectional Survey Study.
Article in Journal of Korean medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
74 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic Review of Smartphone Applications Available for Corona Virus Disease 2019 (COVID19) and the Assessment of their Quality Using the Mobile Application Rating Scale (MARS).Journal of medical systems · 2020Pooled it
- Trial
- Retraction Analysis in Social Media Research: A Scopus Based Data From 2011 to 2025.Journal of Korean medical science · 2026Article
- Publication and Retraction Activity in the Field of Extracorporeal Membrane Oxygenation: Origins, Concerns, and Perspectives.Journal of Korean medical science · 2026Article
- Evaluating Large Language Models for Post-Publication Promotion: A Blinded Comparative Study of Social Media Posts in Public Health.Journal of Korean medical science · 2026Article
- Altmetric Activity and Scientific Integrity: A Retraction Analysis of PubMed-Indexed Social Media-Related Publications.Journal of Korean medical science · 2026Article
- Social media platforms for ethical post-publication promotion.Clinical rheumatology · 2026Article
- Global social media use among rheumatology professionals: the EULAR SoMeR Study Group survey.RMD open · 2025Article
- Social media landscape: a cross-sectional survey of health professionals.Rheumatology international · 2025Article
- Notes from Self-Isolation: Imagination in Times of Ruptures.Integrative psychological & behavioral science · 2025Article
- How Authoritative Media and Personal Social Media Influence Policy Compliance Through Trust in Government and Risk Perception: Quantitative Cross-Sectional Survey Study.Journal of medical Internet research · 2025Article
- Article
- Digital Health and Self-Management in Idiopathic Inflammatory Myopathies: A Missed Opportunity?Current rheumatology reports · 2024Review
- Ethical Considerations in Infodemic Management: Systematic Scoping Review.JMIR infodemiology · 2024Article
- Ethics for Disseminating Health-Related Information on YouTube.Journal of Korean medical science · 2024Article
- YouTube as a Source of Information on Public Health Ethics.Journal of Korean medical science · 2024Article
- The Impact of Social Media on Vaccination: A Narrative Review.Journal of Korean medical science · 2023Review
- Analysis of Retracted Publications in Medical Literature Due to Ethical Violations.Journal of Korean medical science · 2023Article
- GPTZero Performance in Identifying Artificial Intelligence-Generated Medical Texts: A Preliminary Study.Journal of Korean medical science · 2023Article
- Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.Rheumatology international · 2023Article
14 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe coronavirus disease 2019 (COVID-19) pandemic has led to a large volume of publications, a barrage of non-reviewed preprints on various professional repositories and a slew of retractions in a short amount of time.
methodsWe conducted an e-survey using a cloud-based website to gauge the potential sources of trustworthy information and misinformation and analyzed researchers', clinicians', and academics' attitude toward unpublished items, and pre- and post-publication quality checks in this challenging time.
resultsAmong 128 respondents (mean age, 43.2 years; M:F, 1.1:1), 60 (46.9%) were scholarly journal editors and editorial board members. Social media channels were distinguished as the most important sources of information as well as misinformation (81 [63.3%] and 86 [67.2%]). Nearly two in five (62, 48.4%) respondents blamed reviewers, editors, and misinterpretation by readers as additional contributors alongside authors for misinformation. A higher risk of plagiarism was perceived by the majority (70, 58.6%), especially plagiarism of ideas (64.1%) followed by inappropriate paraphrasing (54.7%). Opinion was divided on the utility of preprints for changing practice and changing retraction rates during the pandemic period, and higher rejections were not supported by most (76.6%) while the importance of peer review was agreed upon by a majority (80, 62.5%). More stringent screening by journal editors (61.7%), and facilitating open access plagiarism software (59.4%), including Artificial Intelligence (AI)-based algorithms (43.8%) were among the suggested solutions. Most (74.2%) supported the need to launch a specialist bibliographic database for COVID-19, with information indexed (62.3%), available as open-access (82.8%), after expanding search terms (52.3%) and following due verification by academics (66.4%), and journal editors (52.3%).
conclusionWhile identifying social media as a potential source of misinformation on COVID-19, and a perceived high risk of plagiarism, more stringent peer review and skilled post-publication promotion are advisable. Journal editors should play a more active role in streamlining publication and promotion of trustworthy information on COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.